The activated nociceptors release neuropeptides at the periphery, including calcitonin gene-related peptide (CGRP), substance P and neurokinin A [6]; the levels of CGRP and substance P are elevated during migraine attacks in humans and in animal migraine models [7]. This evidence concerns the gene TAC1 and migraine disorder.